ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹159 Cr | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr |
What is the latest Total Non-Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹74 Cr |
| Mar2021 | ₹45 Cr |
How is Total Non-Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹159 Cr | 62.66 | |
| Mar2024 | ₹98 Cr | 41.80 | |
| Mar2023 | ₹69 Cr | -6.30 | |
| Mar2022 | ₹74 Cr | 65.09 | |
| Mar2021 | ₹45 Cr | - | |
Compare Total Non-Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,510.6 Cr | 1.2% | 1.9% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 1.2% |
1.9% |
7.6% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses